UK MHRA acts to support development of novel devices
This article was originally published in RAJ Devices
The UK Medicines and Healthcare products Regulatory Agency has developed a new section on its website on emerging medical technologies1. The aim is to help companies understand the impact of the medical devices directives on their novel technology and to encourage device sponsors to engage in early dialogue with the agency.
You may also be interested in...
A UK regulator with the MHRA is concerned that bioanalytical laboratories are not being given enough time to do their job properly by drug companies under pressure to ensure their clinical trials remain on schedule.
The UK regulator is expecting a rise in amendments and deviations to ongoing clinical investigations of medical devices due to the COVID-19 pandemic and has issued advice on how companies should manage these.
Work and movement-related restrictions are affecting the ability of companies to provide a timely response to questions relating to their prequalification dossiers.